JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB263337

Human RYK knockout HeLa cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

RYK KO cell lysate available now. KO validated. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 160 bp deletion in exon2 and 1 bp deletion in exon2.
2 Images
Sanger Sequencing - Human RYK knockout HeLa cell lysate (AB263337)
  • Sanger seq

Unknown

Sanger Sequencing - Human RYK knockout HeLa cell lysate (AB263337)

Allele-1 : 1 bp deletion in exon2

Sanger Sequencing - Human RYK knockout HeLa cell lysate (AB263337)
  • Sanger seq

Unknown

Sanger Sequencing - Human RYK knockout HeLa cell lysate (AB263337)

Allele-2 : 160 bp deletion in exon2

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 160 bp deletion in exon2 and 1 bp deletion in exon2.

Disease

Adenocarcinoma

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab263337-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human RYK knockout HeLa cell lysate", "number":"AB263337-CMP02", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HeLa cell lysate", "number":"AB263337-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
RYK
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The receptor-like tyrosine kinase (RYK) also known as RYK receptor-like tyrosine kinase is a protein involved in Wnt signaling pathways. It has a molecular mass of approximately 74 kDa. RYK functions as a single-pass type I membrane protein and primarily acts as a receptor for Wnt proteins. It is expressed in various tissues including brain testis and pancreas reflecting its diverse roles in developmental and physiological processes.
Biological function summary

RYK modulates cellular communication by interacting with Wnt proteins. It does not possess intrinsic kinase activity but participates in signaling as part of a larger receptor complex on the cell surface. This complex includes other proteins such as Frizzled receptors and LRP co-receptors facilitating the translation of extracellular Wnt signals into intracellular responses. RYK although not a conventional kinase plays a pivotal role in neuronal development influencing axon guidance and synaptic formation.

Pathways

RYK is integral to the Wnt signaling pathway which is essential for cell proliferation differentiation and migration. Through the Wnt pathway RYK interacts with other proteins such as Disheveled (Dvl) to execute its signaling functions. Additionally RYK has associations with the non-canonical Wnt/PCP (planar cell polarity) pathway modulating tissue polarity and cell movement during embryogenesis. Its role within these pathways highlights the intricate regulatory networks involved in developmental biology.

RYK has associations with cancer and neurodevelopmental disorders. Aberrant expression or mutations in RYK can contribute to tumor growth and metastasis implicating it in cancers such as glioma. During neurodevelopment alterations in RYK signaling can lead to disorders like autism spectrum disorder (ASD). RYK interacts with proteins such as β-catenin in pathological states influencing the progression of these conditions. Understanding RYK's involvement in these diseases provides insights that could facilitate therapeutic strategies.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com